RxDoctor Payments Data

Jeffrey Scow, MD

Colon & Rectal Surgery · Hershey, PANPI 1255451423

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (30.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 69.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $270 and has fallen 94.4% since, to $15 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in PA, where the typical reported total is $2,089.

$770in general payments, 2019–2025

Across 11 payments — averaging $70.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$534
  • Actuated Medical, Inc.$200
  • Johnson & Johnson$21
  • Acera Surgical, Inc.$15
$289,202in research payments, 2019–2025

Across 96 payments — averaging $3012.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$289K

What the payments were for

  • Consulting fees$20026%
  • Travel & lodging$22830%
  • Food & beverage$23230%
  • Education$11014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical8$534
Actuated Medical, Inc.1$200
Johnson & Johnson1$21
Acera Surgical, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$770 in reported general payments places this provider in the 30th percentile of 108 colon & rectal surgery providers in Pennsylvania.

See all colon & rectal surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$65,042
Medicare patients
133
Services billed
268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole40$79
Neomycin Sulfate18$56
Oxycodone Hcl20$30

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Hershey

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →